Tryptophan 299 is a conserved residue of human pregnane X receptor critical for the functional consequence of ligand binding

被引:12
|
作者
Banerjee, Monimoy [1 ]
Chai, Sergio C. [1 ]
Wu, Jing [1 ]
Robbins, Delira [1 ]
Chen, Taosheng [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Mail Stop 1000,262 Danny Thomas Pl, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
PXR; CYP3A4; Xenobiotic receptor; SAR; Transcriptional regulation; CRYSTAL-STRUCTURE; TRANSACTIVATION ACTIVITY; XENOBIOTIC RECEPTORS; COACTIVATOR BINDING; COMPLEX PROVIDES; PXR; METABOLISM; VARIANTS; CAR; IDENTIFICATION;
D O I
10.1016/j.bcp.2016.02.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PXR is a xenobiotic receptor that regulates drug metabolism by regulating the expression of drug metabolizing enzymes including CYP3A4. It can be modulated by chemicals with different structures, functional groups and sizes. X-ray crystal structures of the ligand binding domain of human PXR (hPXR) alone or bound with agonists reveal a highly hydrophobic ligand binding pocket where the aromatic amino acid residue W299 appears to play a critical role in ligand binding. Here, we have investigated the role of W299 on the functional consequence of hPXR ligand binding. We first found that substitution of W299 with a hydrophobic residue retained its response to rifampicin, but substitution with a charged residue altered such agonist response in activating the transcription of CYP3A4. The activity of hPXR mutants on CYP3A4 expression correlates with the ability of hPXR mutants to interact with co-activator SRC-1. We further demonstrated that the effect of replacing W299 by residues with different side chains on hPXR's function varied depending on the specific agonist used. Finally we interpreted the cellular activity of the hPXR mutants by analyzing reported crystallographic data and proposing a model. Our findings reveal the essential role of W299 in the transactivation of hPXR in response to agonist binding, and provide useful information for designing modulators of hPXR. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [41] Rifampicin - Independent Interactions Between the Pregnane X Receptor Ligand Binding Domain and Peptide Fragments of Co-Activator and Co-Repressor Proteins
    Navaratnarajah, Punya
    Steele, Bridgett L.
    Redinbo, Matthew R.
    Thompson, Nancy L.
    BIOPHYSICAL JOURNAL, 2012, 102 (03) : 193A - 193A
  • [42] Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore Modeling and virtual screening to " in vivo" biological activity
    Lemaire, Geraldine
    Benod, Cindy
    Nahoum, Virginie
    Pillon, Arnaud
    Boussioux, Anne-Marie
    Guichou, Jean-Franc Ois
    Subra, Guy
    Pascussi, Jean-Marc
    Bourguet, William
    Chavanieu, Alain
    Balaguer, Patrick
    MOLECULAR PHARMACOLOGY, 2007, 72 (03) : 572 - 581
  • [43] Both warfarin and vitamin K stimulate the ectopic calcification of human aortic valve interstitial cells through binding to pregnane X receptor
    Seya, Kazuhiko
    Yu, Zaiqiang
    Nomura, Anan
    Daitoku, Kazuyuki
    Motomura, Shigeru
    Murakami, Manabu
    Fukuda, Ikuo
    Furukawa, Ken-Ichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S201 - S201
  • [44] Importance of conserved cysteines in the extracellular loops of human PACAP/VIP1 receptor for ligand binding and stimulation of cAMP production
    Knudsen, SM
    Tams, JW
    Wulff, BS
    Fahrenkrug, J
    VIP, PACAP, AND RELATED PEPTIDES: THIRD INTERNATIONAL SYMPOSIUM, 1998, 865 : 259 - 265
  • [45] ROLE OF THE STRICTLY CONSERVED TRYPTOPHAN-25 RESIDUE IN THE STABILIZATION OF THE STRUCTURE AND IN THE LIGAND-BINDING PROPERTIES OF THE KRINGLE-2 DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    DESERRANO, VS
    CASTELLINO, FJ
    BIOCHEMISTRY, 1994, 33 (06) : 1340 - 1344
  • [46] Multiple ligand-binding properties of the lipocalin member chicken α1-acid glycoprotein studied by circular dichroism and electronic absorption spectroscopy:: The essential role of the conserved tryptophan residue
    Zsila, Ferenc
    Matsunaga, Hisami
    Bikádi, Zsolt
    Haginaka, Jun
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (08): : 1248 - 1273
  • [47] Crystal structure of the human liver X receptor β ligand-binding domain in complex with a synthetic agonist
    Hoerer, S
    Schmid, A
    Heckel, A
    Budzinski, RM
    Nar, H
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 334 (05) : 853 - 861
  • [48] Conservation of DNA and ligand binding properties of retinoid X receptor from the placozoan Trichoplax adhaerens to human
    Reitzel, Adam M.
    Macrander, Jason
    Mane-Padros, Daniel
    Fang, Bin
    Sladek, Frances M.
    Tarrant, Ann M.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 184 : 3 - 10
  • [49] FUNCTIONAL-ANALYSIS OF THE LIGAND-BINDING SITE OF EGF-RECEPTOR UTILIZING CHIMERIC CHICKEN HUMAN RECEPTOR MOLECULES
    LAX, I
    BELLOT, F
    HOWK, R
    ULLRICH, A
    GIVOL, D
    SCHLESSINGER, J
    EMBO JOURNAL, 1989, 8 (02): : 421 - 427
  • [50] Identification of Critical Residues Involved in Ligand Binding and G Protein Signaling in Human Somatostatin Receptor Subtype 2
    Parry, Jesse J.
    Chen, Ronald
    Andrews, Rebecca
    Lears, Kimberly A.
    Rogers, Buck E.
    ENDOCRINOLOGY, 2012, 153 (06) : 2747 - 2755